SCHEMBL1129616

SCHEMBL1129616

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3cccc(CCC(=O)O)c3)c(F)c2)ccn1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 13/20 0.70
MAPK14 Q16539 6/20 0.70
ABL1 P00519 3/20 0.70
RIPK1 Q13546 2/20 0.70
PLK4 O00444 1/20 0.70
ACOX3 O15254 1/20 0.70
MAP3K7 O43318 1/20 0.70
DYRK3 O43781 1/20 0.70
JAK2 O60674 1/20 0.70
ERN1 O75460 1/20 0.70
RPS6KA4 O75676 1/20 0.70
STK10 O94804 1/20 0.70
MAP4K4 O95819 1/20 0.70
RAF1 P04049 1/20 0.70
NTRK1 P04629 1/20 0.70
LCK P06239 1/20 0.70
FYN P06241 1/20 0.70
CDK1 P06493 1/20 0.70
FES P07332 1/20 0.70
CSF1R P07333 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129228 0.92 BRAF (0.67) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL398737 0.92 BRAF (0.74) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL29849902 0.92 BRAF (0.74) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL401917 0.91 BRAF (0.66) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL1128815 0.89 BRAF (0.69) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL2242285 0.89 ABL1 (0.79) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL31265677 0.89 ABL1 (0.79) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL400982 0.89 BRAF (0.70) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL3945328 0.89 BRAF (0.70) BRAFMAPK14ABL1RIPK1PLK4
SCHEMBL2243075 0.89 MAPK14 (0.79) BRAFMAPK14ABL1RIPK1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111401-B1 4-{4-[({3-TERT-BUTYL-1-[3-(HYDROXYMETHYL) PHENYL]-1H-PYRAZOL-5-YL } CARBAMOYL)-AMINO]-3-FLUOROPHENOXY} -N-METHYLPYRIDINE-2-CARBOXAMIDE AS WELL AS PRODRUGS AND SALTS THEREOF FOR THE TREATMENT OF CANCER BAYER HEALTHCARE LLC (US) 2011-02-16 EP claimed